Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114195711B details a novel one-step carbonylation for quinoline-4(1H)-one. This report analyzes cost reduction in API manufacturing and supply chain reliability for global buyers.
Patent CN112239436A details a novel Pd-catalyzed bis-carbonylation route for 4-acyl-2(5H)-furanones, offering safer CO sources and high yields for pharmaceutical intermediates.
Novel copper-catalyzed one-pot method for 2,3-disubstituted indolines. Reduces steps, enhances purity, ensures supply chain reliability for pharmaceutical manufacturing.
Patent CN110577457A enables efficient aryl carboxylic acid synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel Mo/Cu co-catalyzed method offers high yields and mild conditions for scalable production of bioactive heterocycles.
Patent CN102060779A details a copper-catalyzed route for 2-aminobenzimidazoles. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN109776546B details a high-yield Re-catalyzed synthesis of indolopyrrolones, offering cost reduction in pharmaceutical intermediate manufacturing and scalable production.
Patent CN113896648B reveals nickel-catalyzed synthesis reducing toxic gas reliance and enhancing supply chain stability for pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation method for 1,2,4-triazole-3-ones. High yield, broad substrate scope, cost-effective API intermediate manufacturing.
Novel isonitrile-based route for quinoline derivatives. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel iodine-catalyzed reduction method offers high purity intermediates with significant cost and supply chain advantages for pharmaceutical manufacturing processes globally.
Novel Cu(I)-catalyzed cyclization for 2,3-disubstituted indoles. High yield, mild conditions, cost-effective scale-up for pharmaceutical intermediates.
Novel Pd-catalyzed carbonylation method offers high yields and substrate compatibility for scalable API intermediate manufacturing.
Patent CN115772157B reveals cobalt-catalyzed route for 2-alkoxyindoles offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN108069918B reveals a novel one-pot copper-catalyzed method for 3-difluoromethylisoxazoles, offering significant cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN114539198B reveals a novel Pd-catalyzed route for chroman amides. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel base-free alkylation process for Indacaterol Maleate achieving 93% yield. Reduces regioisomers and ensures supply chain stability for respiratory API manufacturing.
Novel Pd-catalyzed carbonylation method offers high yields and broad substrate scope for cost-effective pharmaceutical intermediate manufacturing.
Patent CN111662147B reveals a mild Cu-catalyzed route for diynes. Achieve cost reduction in pharmaceutical intermediate manufacturing with high purity and scalability.
Patent CN104402934B reveals low-loading ruthenium catalysts for green quinoline synthesis, offering cost reduction and supply reliability for pharmaceutical intermediates manufacturing.